Teo Mario, Martin Sean, Ponweera Arachchige, Macey Alistair, Suttner Nigel, Brown Jennifer, St George Jerome
a Department of Neurosurgery , Institute of Neurological Science , Glasgow , UK.
Br J Neurosurg. 2015;29(6):792-8. doi: 10.3109/02688697.2015.1080217. Epub 2015 Sep 4.
It has been 10 years since the publication of International Subarachnoid Aneurysm Trial (ISAT) (1-3) and the first-line treatment for cerebral aneurysms in many UK neurosurgical centres is endovascular occlusion. Local audit has shown a significant reduction in surgical clipping cases since 2002, with a fall from over 150 cases per year pre ISAT, to approximately 25 cases per year currently. More so the cases referred for surgical occlusion represent more challenging lesions. With such a reduction in surgical numbers we felt it prudent to review our recent surgical outcomes.
Retrospective analysis of prospectively collected data.
47 patients (32 females, 15 males), mean age: 53 (range, 29-74) years underwent surgical clipping of cerebral aneurysms from January 2012 to September 2013.
Case notes, neuroradiology reports and cerebral angiograms were reviewed. Patient outcome was stratified according to Glasgow Outcome Score; 4-5 good outcome and 1-3 poor outcome.
Of the aneurysms clipped, 40 patients had suffered a subarachnoid haemorrhage and 7 were treated for unruptured aneurysms. The reasons for referral for surgical clipping were the presence of an aneurysmal clot 9 (19%), 'failed coiling' 16 (34%) and unsuitability for endovascular intervention due to anatomical considerations 22 (47%). A good outcome was recorded in 20/22 (91%) of patients who underwent clipping for anatomical reasons, 11/16 (69%) of patients who failed endovascular treatment and 5/9 (56%) of patients with an aneurysmal clot (p = 0.05). Of 31 aneurysms with post clipping angiographic studies, 28 (90%) had complete or satisfactory aneurysm obliteration.
In the current era of neurointerventional dominance, the case mix undergoing microsurgical clipping is more challenging than the pre-ISAT cohort; however, post-procedural angiography has demonstrated a relatively high obliteration rate. It is reassuring that good neurological outcomes were observed in patients clipped for anatomical reasons.
自《国际蛛网膜下腔动脉瘤试验》(ISAT)发表(1 - 3)已有10年,在英国许多神经外科中心,脑动脉瘤的一线治疗方法是血管内栓塞。本地审计显示,自2002年以来,手术夹闭病例显著减少,从ISAT之前每年超过150例降至目前每年约25例。更有甚者,转诊进行手术栓塞的病例代表了更具挑战性的病变。鉴于手术例数如此减少,我们认为审慎地回顾一下我们近期的手术结果是明智的。
对前瞻性收集的数据进行回顾性分析。
2012年1月至2013年9月,47例患者(32例女性,15例男性),平均年龄53岁(范围29 - 74岁)接受了脑动脉瘤手术夹闭。
查阅病历、神经放射学报告和脑血管造影。根据格拉斯哥预后评分对患者预后进行分层;4 - 5分为良好预后,1 - 3分为不良预后。
在接受夹闭的动脉瘤患者中,40例曾发生蛛网膜下腔出血,7例为未破裂动脉瘤接受治疗。转诊进行手术夹闭的原因包括存在动脉瘤血栓9例(19%)、“弹簧圈栓塞失败”16例(34%)以及因解剖学考虑不适合血管内介入治疗22例(47%)。因解剖学原因接受夹闭的患者中,20/22例(91%)预后良好;血管内治疗失败的患者中,11/16例(69%)预后良好;有动脉瘤血栓的患者中,5/9例(56%)预后良好(p = 0.05)。在31例术后进行血管造影研究的动脉瘤中,28例(90%)动脉瘤完全或满意闭塞。
在当前神经介入占主导地位的时代,接受显微手术夹闭的病例组合比ISAT之前的队列更具挑战性;然而,术后血管造影显示闭塞率相对较高。令人欣慰的是,因解剖学原因接受夹闭的患者观察到了良好的神经学预后。